₹1,698.00-55.90 (-3.19%)
04:01 PM, 16-Jan-2026₹1,704.20-49.40 (-2.82%)
03:48 PM, 16-Jan-2026BSE : 543245
NSE : GLAND
Sector : Health care
ISIN Code : INE068V01023
Last Updated: 16-Jan-2026 | 04:01 PM IST
| Market Cap (₹ Cr) | 27,983 |
Traded Value (₹ Cr) | 0.47 |
Volume (Shares) | 2,772 |
Face Value (₹) | 1 |
52-Week High (₹) | 2,130.00 |
52-Week High Date | 29-Jul-2025 |
52-Week Low (₹) | 1,200.00 |
52-Week Low Date | 07-Apr-2025 |
All Time High (₹) | 4,350.00 |
All Time High Date | 12-Aug-2021 |
All Time Low (₹) | 861.50 |
All Time Low Date | 22-May-2023 |
| PARAMETER | VALUES |
|---|---|
| Market Cap (₹ Cr) | 28,085 |
| EPS - TTM (₹) [C] | 47.97 |
| P/E Ratio (X) [C] | 35.53 |
| Face Value (₹) | 1 |
| Latest Dividend (%) | 1,800.00 |
| Latest Dividend Date | 14-Aug-2025 |
| Dividend Yield (%) | 1.03 |
| Book Value Share (₹) [C] | 580.41 |
| P/B Ratio (₹) [C] | 2.94 |
| Scheme Name | Amount Invested (₹ Cr) | No Of Shares | Net Asset (%) |
|---|---|---|---|
| HDFC Mid Cap Fund - Regular (G) | 1009.12 | 58,60,179 | 1.09 |
| HDFC Mid Cap Fund - Regular (IDCW) | 1009.12 | 58,60,179 | 1.09 |
| HDFC Mid Cap Fund - Direct (IDCW) | 1009.12 | 58,60,179 | 1.09 |
| HDFC Mid Cap Fund - Direct (G) | 1009.12 | 58,60,179 | 1.09 |
| SBI Large & Midcap Fund (IDCW) | 545.87 | 31,70,000 | 1.46 |
| SBI Large & Midcap Fund (G) | 545.87 | 31,70,000 | 1.46 |
| SBI Large & Midcap Fund - Direct (G) | 545.87 | 31,70,000 | 1.46 |
| SBI Large & Midcap Fund - Direct (IDCW) | 545.87 | 31,70,000 | 1.46 |
| Mirae Asset Large & Midcap Fund - Regular (G) | 535.65 | 31,10,648 | 1.22 |
| Mirae Asset Large & Midcap Fund - Regular (IDCW) | 535.65 | 31,10,648 | 1.22 |
Load more
| Date | Broker | Action | Prices(₹) | Report |
|---|---|---|---|---|
| 25-Sep-2025 | Motilal Oswal | Buy | 2,340 | |
| 04-Feb-2025 | Elara Capital | Buy | 1,841 | |
| 06-Nov-2024 | Motilal Oswal | Buy | 1,970 |
| Today's Low/High (₹) | 1,696.00 1,761.80 |
| Week Low/High (₹) | 1,657.50 1,761.80 |
| Month Low/High (₹) | 1,629.60 1,790.00 |
| Year Low/High (₹) | 1,277.80 2,131.00 |
| All time Low/High (₹) | 861.50 4,350.00 |
| Period | BSE | NSE | SENSEX | NIFTY |
|---|---|---|---|---|
| 1 Week | 1.40% | 1.40% | -0.01% | 0.04% |
| 1 Month | 2.42% | 2.39% | -1.31% | -0.64% |
| 3 Month | -11.24% | -11.13% | 0.12% | 0.43% |
| 6 Month | -13.53% | -13.53% | 1.13% | 1.91% |
| 1 Year | 1.61% | 1.69% | 8.47% | 10.22% |
| 3 Year | 17.97% | 17.97% | 39.07% | 43.59% |
Chairman / Executive Director / MD / CEO : SRINIVAS SADU
Independent Non Exe. Director : UDO JAHANNES VETTER
Independent Non Exe. Director : Satyanarayana Murthy Chavali
Independent Non Exe. Director : ESSAJI GOOLAM VAHANVATI
Non-Exec & Non-Independent Dir : Jia Ai (Allen) Zhang
Independent Non Exe. Director : Naina Lal Kidwai
Non-Exec & Non-Independent Dir : Wenjie Zhang
Non-Exec & Non-Independent Dir : Wei Huang
CS / Compliance Officer / Vice President : SAMPATH KUMAR PALLERLAMUDI
Registered Office: Sy No 143-148 150&151 Nr Gandi, X Roads D P Pally Dundigal,Hyderabad,Telangana-500043 Ph: 91-40-30510999
1. What's the Gland Pharma Ltd share price today?
Gland Pharma Ltd share price was Rs 1,698.00 at 04:01 PM IST on 16th Jan 2026. Gland Pharma Ltd share price was down by 3.19% from the previous closing price of Rs 1,753.90. Gland Pharma Ltd share price trend:
2. How can I quickly analyse the performance of the Gland Pharma Ltd stock?
The performance of the Gland Pharma Ltd stock can be quickly analysed on the following metrics:
3. What is the market cap of Gland Pharma Ltd?
Gland Pharma Ltd has a market capitalisation of Rs 27,983 crore.
4. What is Gland Pharma Ltd's 52-week high/low share price?
The Gland Pharma Ltd’s 52-week high share price is Rs 2,130.00 and 52-week low share price is Rs 1,200.00.
5. Is the Gland Pharma Ltd profitable?
On a consolidated basis, Gland Pharma Ltd reported a profit of Rs 183.68 crore on a total income of Rs 1,571.04 crore for the quarter ended 2025.
6. Which are Gland Pharma Ltd’s peers in the Health care sector?
Gland Pharma Ltd’s top 5 peers in the Health care sector are Ajanta Pharma, J B Chemicals &, Emcure Pharma, Gland Pharma, Wockhardt, Piramal Pharma, Pfizer.
7. Who owns how much in Gland Pharma Ltd?
Key changes to the Gland Pharma Ltd shareholding are as follows: